Cargando…
Oncosuppressor-Mutated Cells as a Liquid Biopsy Test for Cancer-Screening
We reported on the ability of immortalized or oncosuppressor-mutated cells (OMCs) to uptake circulating cancer-factors and give tumors when transplanted into mice. This led to the first biological based liquid biopsy test, which we called MATER-D platform. In the present study, we showed for the fir...
Autores principales: | Abdouh, Mohamed, Gao, Zu-Hua, Arena, Vincenzo, Arena, Manuel, Burnier, Miguel N., Arena, Goffredo Orazio |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382857/ https://www.ncbi.nlm.nih.gov/pubmed/30787346 http://dx.doi.org/10.1038/s41598-019-38736-y |
Ejemplares similares
-
Exosomes isolated from cancer patients’ sera transfer malignant traits and confer the same phenotype of primary tumors to oncosuppressor-mutated cells
por: Abdouh, Mohamed, et al.
Publicado: (2017) -
Transfer of malignant trait to BRCA1 deficient human fibroblasts following exposure to serum of cancer patients
por: Hamam, Dana, et al.
Publicado: (2016) -
Colorectal cancer-derived extracellular vesicles induce transformation of fibroblasts into colon carcinoma cells
por: Abdouh, Mohamed, et al.
Publicado: (2019) -
Novel blood test to predict neoplastic activity in healthy patients and metastatic recurrence after primary tumor resection
por: Abdouh, Mohamed, et al.
Publicado: (2016) -
Reprogramming Malignant Cancer Cells toward a Benign Phenotype following Exposure to Human Embryonic Stem Cell Microenvironment
por: Zhou, Shufeng, et al.
Publicado: (2017)